Impact of Pharmacist Intervention on Selection and Timing of Appropriate Antimicrobial Therapy in Septic Shock

Abstract

Background:

Current guidelines for septic shock management recommend administration of appropriate, broad-spectrum antimicrobials within 1 hour of recognition.

Objective:

To evaluate the interventions pharmacists make as part of a sepsis response team and to determine if these interventions increase the proportion of patients with appropriate empiric antimicrobial therapy.

Methods:

A retrospective cohort study was undertaken reviewing adult patients in a large, academic medical center with confirmed septic shock who had an order for a “sepsis bundle,” which includes notification of a pharmacist to assess adequacy of empiric therapy. Pharmacist interventions with regard to selection of empiric antimicrobials were documented. The proportion of patients with initial successful selection of antimicrobial therapy (SSAT) before and after pharmacist intervention was assessed as well as the time to first antimicrobial administration and time to appropriate antimicrobial administration.

Results:

A total of 76 patients were included. Pharmacist intervention increased the proportion of patients with SSAT from 66% to 80% (P = .04). Median time to first antimicrobial administration was 43 minutes, and time to appropriate antimicrobial therapy was 1 hour, 34 minutes for the entire cohort, with pharmacist intervention decreasing the latter time significantly in patients without SSAT on initiation of the “sepsis bundle” (P < .001).

Conclusion:

Pharmacist assessment of patients in septic shock offers the opportunity to improve SSAT. Systems designed to use a pharmacist responder for the care of patients with septic shock maximize the selection of antimicrobials, facilitate rapid administration, and improve surrogate outcomes for mortality in septic shock.

Keywords

critical care antibiotic septic shock pharmacist

Get full access to this article

View all access options for this article.

References

Ferrer

Martin-Loeches

Phillips

. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749–1755.

Dellinger

Levy

Rhodes

. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41(2):580–637.

Kumar

Roberts

Wood

. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–1596.

Sebat

Musthafa

Johnson

. Effect of a rapid response system for patients in shock on time to treatment and mortality during 5 years. Crit Care Med. 2007;35(11):2568–2575.

Shapiro

Howell

Talmor

. Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med. 2006;34(4):1025–1032.

Weant

Baker

. Emergency medicine pharmacists and sepsis management. J Pharm Pract. 2013;26(4):401–405.

Flynn

McConeghy

Flannery

. Utilization of pharmacist responders as a component of a multidisciplinary sepsis bundle. Ann Pharmacother. 2014;48(9):1145–1151.

Gaieski

Mikkelsen

Band

. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med. 2010;38(4):1045–1053.

Kaboli

Hoth

McClimon

. Clinical pharmacists and inpatient medical care: a systematic review. Arch Intern Med. 2006;166(9):955–964.

10.

Jellinek

Cohen

Fancher

. Pharmacist improves timely administration of medications to boarded patients in the emergency department. J Emerg Nurs. 2010;36(2):105–110.

11.

Draper

Eppert

. Association of pharmacist presence on compliance with advanced cardiac life support guidelines during in-hospital cardiac arrest. Ann Pharmacother. 2008;42(4):469–474.

12.

Acquisto

Hays

Fairbanks

. The outcomes of emergency pharmacist participation during acute myocardial infarction. J Emerg Med. 2012;42(4):371–378.

13.

Prelaski

Lat

MacLaren

. Pharmacist contributions as members of the multidisciplinary ICU team. Chest. 2013;144(5):1687–1695.

14.

Rudis

Brandl

. Position paper on critical care pharmacy services. Society of Critical Care Medicine and American College of Clinical Pharmacy Task Force on Critical Care Pharmacy Services. Crit Care Med. 2000;28(11):3746–3750.

15.

The Joint Commission. Specifications Manual for National Hospital Inpatient Quality Measures.v.5.0a. http://www.jointcommission.org/specifications_manual_for_national_hospital_inpatient_quality_measures.aspx. Published July 1, 2016. Updated October 20, 2016. Accessed August 19, 2015.

16.

Zilberberg

Shorr

Micek

. Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study. Crit Care. 2014;18(6):596.

17.

Sterling

Miller

Pryor

. The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis. Crit Care Med. 2015;43(9):1907–1915.

18.

Sivapalan

Jensen

. Timing of Therapy in Sepsis: Are Early Antibiotics Important for Prognosis? Crit Care Med. 2015;43(9):2030–2031.

19.

Zilberberg

Shorr

. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009. J Hosp Med. 2013;8(10):559–563.

20.

Sievert

Ricks

Edwards

. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol. 2013;34(1):1–14.